Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Bone Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT05060653
What this trial is testing

Stereotactic Body Radiotherapy Followed by Surgical Stabilization in Spinal Metastases

Who this might be right for
Spinal NeoplasmsNeoplasm MetastasisRadiosurgery+1 more
UMC Utrecht
Testing effectiveness (Phase 2)Ended earlyNCT00019695
What this trial is testing

Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate CancerBone MetastasesAdenocarcinoma of the Prostate+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00003913
What this trial is testing

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 390
Large-scale testing (Phase 3)Study completedNCT00685646
What this trial is testing

Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 227
Not applicableUnknownNCT02145286
What this trial is testing

Phase 1/2 Study to Determine Optimal Dose for Treating Bone Metastases Using Novel STAT-RT Workflow

Who this might be right for
Metastatic Bone Lesion
Paul W. Read, MD 47
Not applicableStudy completedNCT03419442
What this trial is testing

Multi-academic Center Study of Xofigo Patients

Who this might be right for
Prostate Cancer, Castration Resistant
Bayer 150
Testing effectiveness (Phase 2)Study completedNCT00053001
What this trial is testing

Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome

Who this might be right for
AnemiaLeukemiaMyelodysplastic Syndromes+1 more
Fallon Clinic
Post-approval studies (Phase 4)WithdrawnNCT00242528
What this trial is testing

Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.

Who this might be right for
Multiple Myeloma
Novartis
Testing effectiveness (Phase 2)Study completedNCT01349972
What this trial is testing

Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+13 more
National Cancer Institute (NCI) 172
Testing effectiveness (Phase 2)Study completedNCT01361464
What this trial is testing

Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+13 more
National Cancer Institute (NCI) 21
Not applicableStudy completedNCT00874211
What this trial is testing

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Who this might be right for
Breast CancerLung CancerMetastatic Cancer+4 more
SWOG Cancer Research Network 3,571
Testing effectiveness (Phase 2)Study completedNCT00066365
What this trial is testing

Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma

Who this might be right for
Metastatic CancerSarcoma
Children's Oncology Group 49
Not applicableLooking for participantsNCT03304730
What this trial is testing

Prognostic Factors in Zygapophyseal Osteoarthritis Infiltration: a Prospective Cohort Study

Who this might be right for
Degenerative Arthropathy of Lumbar Spinal Facet Joint
Hospital Israelita Albert Einstein 147
Testing effectiveness (Phase 2)WithdrawnNCT01665651
What this trial is testing

Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy

Who this might be right for
Renal Insufficiency, ChronicRenal Osteodystrophy
Bing Shu
Testing effectiveness (Phase 2)Study completedNCT00425477
What this trial is testing

Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Large-scale testing (Phase 3)Study completedNCT01288378
What this trial is testing

Empirical Versus Preemptive Antifungal Therapy

Who this might be right for
Fungal InfectionLeukemiaMyelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 556
Early research (Phase 1)Temporarily pausedNCT06549478
What this trial is testing

Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the BoneMetastatic Malignant Solid Neoplasm
City of Hope Medical Center 24
Testing effectiveness (Phase 2)Ended earlyNCT00509249
What this trial is testing

Aflibercept in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
Atypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Myelomonocytic Leukemiade Novo Myelodysplastic Syndromes+3 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT02484443
What this trial is testing

Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma

Who this might be right for
Metastatic Malignant Neoplasm in the LungMetastatic OsteosarcomaRecurrent Osteosarcoma
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT00732316
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Asan Medical Center 54
Next Page